Neurocrine Biosciences Stock Options
| NBIX Stock | USD 138.10 0.24 0.17% |
Neurocrine Biosciences' latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.5. The total put volume is at 1.0. The Neurocrine Biosciences option chain provides detailed quote and price information for the current Neurocrine Biosciences option contracts. It shows all of Neurocrine Biosciences' listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on Neurocrine Biosciences
Analyzing Neurocrine Biosciences' in-the-money options over time can help investors to take a profitable long position in Neurocrine Biosciences regardless of its overall volatility. This is especially true when Neurocrine Biosciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Neurocrine Biosciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Neurocrine Biosciences' stock while costing only a fraction of its price.
Neurocrine Current Options Market Mood
Neurocrine Biosciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Neurocrine Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Neurocrine Biosciences' options investors are not very successful. Neurocrine Biosciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Neurocrine contract
Base on the Rule 16, the options market is currently suggesting that Neurocrine Biosciences will have an average daily up or down price movement of about 0.0313% per day over the life of the 2025-01-17 option contract. With Neurocrine Biosciences trading at USD 138.1, that is roughly USD 0.0432. If you think that the market is fully incorporating Neurocrine Biosciences' daily price movement you should consider buying Neurocrine Biosciences options at the current volatility level of 0.5%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Neurocrine |
Purchasing Neurocrine Biosciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Neurocrine calls. Remember, the seller must deliver Neurocrine Biosciences stock to the call owner when a call is exercised.
Neurocrine Biosciences Option Chain
When Neurocrine Biosciences' strike price is surpassing the current stock price, the option contract against Neurocrine Biosciences stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Neurocrine Biosciences' option chain is a display of a range of information that helps investors for ways to trade options on Neurocrine. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Neurocrine. It also shows strike prices and maturity days for a Neurocrine Biosciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | NBIX250117C00075000 | 0 | 75.0 | 46.2 - 51.0 | 46.2 | In |
Call | NBIX250117C00080000 | 0 | 80.0 | 41.1 - 46.0 | 41.1 | In |
Call | NBIX250117C00085000 | 0 | 85.0 | 36.9 - 41.0 | 36.9 | In |
Call | NBIX250117C00090000 | 0 | 90.0 | 32.2 - 36.0 | 32.2 | In |
Call | NBIX250117C00095000 | 0 | 95.0 | 27.2 - 31.0 | 27.2 | In |
Call | NBIX250117C00100000 | 0 | 100.0 | 22.6 - 26.5 | 22.6 | In |
Call | NBIX250117C00105000 | 0 | 105.0 | 17.9 - 22.0 | 17.9 | In |
Call | NBIX250117C00110000 | 0 | 110.0 | 13.5 - 17.5 | 13.5 | In |
Call | NBIX250117C00115000 | 0 | 115.0 | 9.7 - 13.2 | 9.7 | In |
Call | NBIX250117C00120000 | 0 | 120.0 | 6.1 - 10.0 | 6.1 | In |
Put | NBIX250117P00075000 | 0 | 75.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250117P00080000 | 0 | 80.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250117P00085000 | 0 | 85.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250117P00090000 | 0 | 90.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250117P00095000 | 0 | 95.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250117P00100000 | 0 | 100.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250117P00105000 | 0 | 105.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250117P00110000 | 0 | 110.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250117P00115000 | 0 | 115.0 | 0.0 - 4.8 | 4.8 | |
Put | NBIX250117P00120000 | 0 | 120.0 | 1.5 - 5.8 | 2.6 |
Neurocrine Biosciences Market Cap Over Time
Market Cap |
| Timeline |
Neurocrine Total Stockholder Equity
Total Stockholder Equity |
|
Neurocrine Biosciences Corporate Management
| Julie Cooke | Chief People Officer | Profile | |
| Matthew Abernethy | Chief Officer | Profile | |
| Eric Benevich | Chief Commercial Officer | Profile | |
| Darin Lippoldt | Chief Legal Officer | Profile | |
| Jude Onyia | Chief Officer | Profile | |
| Dimitri Grigoriadis | Chief Research Officer | Profile | |
| Kyle Gano | Chief Business Development Officer | Profile |
Additional Tools for Neurocrine Stock Analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.